Asia-Pacific Medical Affairs Outsourcing Market

Market Introduction

APAC includes countries such as China, Japan, India, Australia, South Korea, and the Rest of APAC. This region accounted for being fastest-growing region of the global Medical Affairs Outsourcing Market in 2019 owing to increasing Cost efficiency and high level of quality offered by the CROs; rise in the government funding for the introduction of new medical affairs outsourcing; growing healthcare expenditure; rising number of hospitals in India and China; expanding research base across India, China, and Japan; and increasing incidences of chronic and acute and infectious diseases.  

Countries in APAC are facing an increasing incidence of COVID-19. Currently, India is the second worst-hit country worldwide. The COVID-19 pandemic has severely impacted the region; however, it has also allowed stakeholders to realign their future path based on strategic intent and focus. India and China are the most preferred destinations for outsourcing, where a large pool of skilled labor is available at a lower cost. With the increasing pressure to reduce manufacturing costs and accelerate time-to-market, many devices and diagnostics companies are looking to conduct clinical trial operations in APAC. Countries such as China, Japan, Singapore, and South Korea are seeing an increased interest in clinical trials. High costs in western countries are also contributing to the flow of medical affairs outsourcing to APAC. To expand sales to the Asian market, pharmaceutical companies are becoming aware of new and changing regulatory environments for drugs, devices, and in-vitro diagnostics. New or improved regulations are implemented frequently in Asia, including changes in GMP standards, drug price controls, and medical device regulatory systems. Third-party guidance and advice are required as part of any acquisition or any improvement of current standards. Increasingly, third-party outsourcing service providers are playing a greater role in supporting and managing the delivery of the key business functions like drug development, sales and marketing, and regulatory compliance services in APAC.                             

Market Overview and Dynamics

The medical affairs outsourcing market in APAC is expected to grow from US$ 356.69 million in 2020 to US$ 776.42 million by 2027; it is estimated to grow at a CAGR of 11.8% from 2020 to 2027. The drug development and discovery is time-consuming and expensive process. The process from early discovery or design to development to regulatory approval can take more than 10 to 15 years. Throughout the development phase of a drug substance, various testing services are required to check the quality and efficacy of the product. Therefore, the pharmaceutical and biotechnology companies prefer to outsource the services to the contract research organizations (CROs) in order to save the cost and time, which is expected to drive the growth of the market.    

Key Market Segments

APAC medical affairs outsourcing market is segmented into services, application, and country. The APAC medical affairs outsourcing market, by services, is segmented into medical writing and publishing, medical monitoring, medical science liaisons (MSLs), medical information, and others. The medical writing and publishing segment held the largest share of the market in 2019. Based on application, the APAC medical affairs outsourcing market is segmented into pharmaceutical, biopharmaceutical, and medical devices. The medical devices market is further segmented into therapeutic medical devices, and diagnostic medical devices. The pharmaceutical segment held the largest share of the market in 2019. Based on country, the APAC medical affairs outsourcing market is segmented into Australia, China, India, Japan, South Korea, and rest of APAC. China held the largest market share in 2019.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the medical affairs outsourcing market in APAC are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are ICON PLC, Indegene, IQVIA Inc, PAREXEL INTERNATIONAL CORPORATION, PPD Inc, Syneos Health, UDG Healthcare plc., and WuXi AppTec.          

Reasons to buy report

• To understand the APAC medical affairs outsourcing market landscape and identify market segments that are most likely to guarantee a strong return.
• Stay ahead of the race by comprehending the ever-changing competitive landscape for APAC medical affairs outsourcing market.
• Efficiently plan M&A and partnership deals in APAC medical affairs outsourcing market by identifying market segments with the most promising probable sales.
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form APAC medical affairs outsourcing market.
• Obtain market revenue forecast for market by various segments from 2021-2028 in APAC region.

APAC Medical Affairs Outsourcing Market Segmentation

APAC Medical Affairs Outsourcing Market - By Services

• Medical Writing and Publishing
• Medical Science Liaisons (MSLs)
• Medical Information
• Medical Monitoring
• Others

APAC Medical Affairs Outsourcing Market - By Application

• Pharmaceuticals
• Medical Devices
• Biopharmaceutical

APAC Medical Affairs Outsourcing Market - By Country

• Australia
• China
• India
• Japan
• South Korea
• Rest of APAC

APAC Medical Affairs Outsourcing Market - Company Profiles

• ICON PLC
• Indegene
• IQVIA Inc
• PAREXEL INTERNATIONAL CORPORATION
• PPD Inc
• Syneos Health
• UDG Healthcare plc.
• WuXi AppTec

Asia-Pacific Medical Affairs Outsourcing Market Strategic Insights

Asia-Pacific Medical Affairs Outsourcing Market Segmentation Analysis

Asia-Pacific Medical Affairs Outsourcing Market Report Highlights

Asia-Pacific Medical Affairs Outsourcing Report Scope

Asia-Pacific Medical Affairs Outsourcing Market Country and Regional Insights